Open AccessUNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models
Author(s) -
Deborah DeRyckere,
Alisa B. LeeSherick,
Madeline G. Huey,
Amanda A. Hill,
Jeffrey W. Tyner,
Kristen M. Jacobsen,
Lauren S. Page,
Gregory Kirkpatrick,
Fatma Eryildiz,
Stephanie A. Montgomery,
Weihe Zhang,
Xiaodong Wang,
Stephen V. Frye,
H Shelton Earp,
Douglas K. Graham
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/wa7e-m156
Subject(s) - methotrexate , mertk , leukemia , small molecule , medicine , pharmacology , chemistry , cancer research , biochemistry , receptor , receptor tyrosine kinase
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom